Antisense oligonucleotides
There are few disease-modifying therapeutics for neurodegenerative diseases, but successes on the development of antisense oligonucleotide (ASO) therapeutics for spinal muscular atrophy and Duchenne muscular dystrophy predict a robust future for ASOs in medicine. Indeed, existing pipelines for the d...
Saved in:
| Main Authors: | , , |
|---|---|
| 格式: | Revisão |
| 语言: | 英语 |
| 出版: |
2019
|
| 在线阅读: | https://doi.org/10.1212/nxg.0000000000000323 https://ng.neurology.org/content/nng/5/2/e323.full.pdf |
| 标签: |
添加标签
没有标签, 成为第一个标记此记录!
|